CROI 2024 Program Guide

Poster Sessions

Poster Session-G3 | Should I Stay or Should I Go: Switching Oral Antiretroviral Therapy 2:30 PM - 4:00 PM • Poster Hall C-D

Switching From a Second-Line Boosted PI Regimen to B/F/TAF: Results of a Randomized Clinical Trial Samuel Pierre , Jean Bernard Marc, Fabienne Homeus, Guirlaine Rivette Bernadin, Letizia Trevisi, Evens Jean, Emelyne Dumont, Sanjana Sundaresan, Vanessa Rivera, Dennis Israelski, Sean E Collins, Jean W Pape, Patrice Severe, Paul E Sax, Serena Koenig Phase II Study of Switch to Daily BIC + LEN in Individuals on a Multitablet HIV Treatment Regimen Karam Mounzer , Jihad Slim, Moti Ramgopal, Malcolm Hedgcock, Mark Bloch, Jorge Santana, Ines Mendes, Ying Guo, Priyanka Arora, Jairo M Montezuma-Rusca, Hal Martin, Peter Sklar, Jared Baeten, Sorana Segal-Maurer A Randomized Trial Switching Adults ≥ 60 Years Old From First Line ART to B/F/TAF: Week 48 Results Loice A. Ombajo , Jeremy Penner, Joseph Nkuranga, Edwin Otieno, Victor Mbewa, Jared O Mecha, Simon Wahome, Florentius Ndinya, Sanjay Bhagani, Anton Pozniak, for the B/F/TAF Study Group Sergio Serrano-Villar, Laura Martín-Pedraza , Carmen Busca, Juan Manuel Tiraboschi, Jesús Santos, Luis Fernando López-Cortés, Carmen Hidalgo Tenorio, Vicente Estrada, María José Crusells Canales, Alfonso Cabello Úbeda, Alberto Díaz de Santiago, María Novella, Miguel Torralba, Marta De Miguel, Santiago Moreno Switching to DTG+3TC vs 3-Drug Regimens in Routine Clinical Care: Long-Term Swedish Data Erik Sörstedt , George Nduva, Saara Hiltunen, Johanna Repits, Fredrik Månsson, Åsa Mellgren, Eva Fernvik, Adam Stubbs, Melanie Schroeder, Johanna Brännström, Christina Carlander Impact of Switch to 3TC/DTG on the HIV-1 Transcriptional Reservoir in a Randomized Controlled Trial Evy E. Blomme , Evelien De Smet, Mareva Delporte, Wim Trypsteen, Sophie Degroote, Sophie Vanherrewege, Els Caluwe, Marie-Angélique De Scheerder, Linos Vandekerckhove Impact of DTG+3TC as First-Line ART on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood Jose Molto , Maria C Garcia-Guerrero, Lucía Bailón, Igor Moraes Cardoso, Ester Aparicio, Pep Coll, Angel Rivero, Elias P Rosen, Jacob D Estes, Julià Blanco, Alex Olvera, Maria C Puertas, Beatriz Mothe, Javier Martinez-Picado, for the DUALITY Study Group Impact of Switching From Dual to Triple Therapy on Inflammation: INSTINCT Study

641 LB

Poster Sessions • Tuesday

642

643

644 NIS

645

646 NIS

647

CROI 2024 117

New Investigator Scholarship

LB

NIS

Late-Breaking